Synthesis, Molecular Modeling, and Selective Inhibitory Activity against Human Monoamine Oxidases of 3-Carboxamido-7-Substituted Coumarins

被引:162
作者
Chimenti, Franco [1 ]
Secci, Daniela [1 ]
Bolasco, Adriana [1 ]
Chimenti, Paola [1 ]
Bizzarri, Bruna [1 ]
Granese, Arianna [1 ]
Carradori, Simone [1 ]
Yanez, Matilde [2 ]
Orallo, Francisco [2 ]
Ortuso, Francesco [3 ]
Alcaro, Stefano [3 ]
机构
[1] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farm, I-00185 Rome, Italy
[2] Univ Santiago de Compostela, Fac Farm, Dept Farmacol, E-15782 La Coruna, Spain
[3] Univ Catanzaro Magna Graecia, Dipartimento Sci Farmacobiol, I-88021 Roccelletta Di Borgia, CZ, Italy
关键词
MAO-A; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; OXIDATIVE STRESS; DERIVATIVES; ANTIDEPRESSANTS; PREDICTION; MECHANISM; COMPLEX; TARGET;
D O I
10.1021/jm801496u
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A large series of 3-carboxamido-7-substituted cournarins have been synthesized and tested in vitro for their human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitory activity. Taking into account all the relevant structural information on MAOs reported in the literature, we made some changes in the coumarin nucleus and examined with particular attention the effect on activity and selectivity of substituting at position 3 with N-aryl or N-alkyl carboxamide and at position 7 with a benzyloxy or a 4'-F-benzyloxy group. Some of the assayed compounds proved to be potent, selective inhibitors of hMAO-B with IC50 values in the micromolar range. To better understand the enzyme-inhibitor interaction and to explain the selectivity of the most active compounds toward hMAOs, molecular modeling studies were carried out on new, high resolution, hMAO-A and hMAO-B crystallographic structures.
引用
收藏
页码:1935 / 1942
页数:8
相关论文
共 56 条
[1]
ABRAHAM P, 1963, INDIAN J APPL CHEM, V26, P168
[2]
Quasi flexible automatic docking processing for studying stereoselective recognition mechanisms, part 2:: Prediction of ΔΔG of complexation and 1H-NMR NOE correlation [J].
Alcaro, S. ;
Gasparrini, F. ;
Incani, O. ;
Caglioti, L. ;
Pierini, M. ;
Villani, C. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2007, 28 (06) :1119-1128
[3]
Neurodegenerative diseases and oxidative stress [J].
Barnham, KJ ;
Masters, CL ;
Bush, AI .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) :205-214
[4]
SPECTRES IR DE QUELQUES DERIVES 3-ACYL DE LA COUMARINE [J].
BASSIGNANA, P ;
COGROSSI, C .
TETRAHEDRON, 1964, 20 (12) :2859-&
[5]
The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[6]
Bezuglov VV, 1997, BIOORG KHIM+, V23, P310
[7]
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].
Binda, C ;
Newton-Vinson, P ;
Hubálek, F ;
Edmondson, DE ;
Mattevi, A .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26
[8]
Recent development of monoamine oxidase inhibitors [J].
Bolasco, A ;
Fioravanti, R ;
Carradori, S .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (12) :1763-1782
[9]
SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF 2-OXO-(2H) 1-BENZOPYRAN-3-CARBOXAMIDE DERIVATIVES [J].
BONSIGNORE, L ;
LOY, G ;
SECCI, D ;
CALIGNANO, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1993, 28 (06) :517-520
[10]
Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase [J].
Brühlmann, C ;
Ooms, F ;
Carrupt, PA ;
Testa, B ;
Catto, M ;
Leonetti, F ;
Altomare, C ;
Carotti, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (19) :3195-3198